Results 211 to 220 of about 470,180 (259)
Some of the next articles are maybe not open access.
Endocrinology and Metabolism Clinics of North America, 1994
Prostate carcinoma is a growing concern in our aging society. While the disease often follows a indolent course, it is the second leading cause of cancer-related deaths in males. Prostate cancer screening is promising but remains unproven and controversial. The therapy of prostate cancer has changed little over the past 10 years.
W J, Ellis, P H, Lange
+7 more sources
Prostate carcinoma is a growing concern in our aging society. While the disease often follows a indolent course, it is the second leading cause of cancer-related deaths in males. Prostate cancer screening is promising but remains unproven and controversial. The therapy of prostate cancer has changed little over the past 10 years.
W J, Ellis, P H, Lange
+7 more sources
Disease-a-Month, 1991
Prostate cancer is the most common malignancy in men and the second leading cause of cancer deaths. Although the mortality rate for prostate cancer has remained unchanged for 50 years, new advances have changed classic concepts in the diagnosis and management of patients with this disease.
R A, Badalament, J R, Drago
openaire +2 more sources
Prostate cancer is the most common malignancy in men and the second leading cause of cancer deaths. Although the mortality rate for prostate cancer has remained unchanged for 50 years, new advances have changed classic concepts in the diagnosis and management of patients with this disease.
R A, Badalament, J R, Drago
openaire +2 more sources
Medical Clinics of North America, 1999
Prostate cancer is the second leading cause of cancer death in men. Recommendations for screening and treatment are usually made, especially in the popular press, without regard to patient age or medical health. This article focuses on the trade-off between the benefits and side effects of screening and treatment.
L E, Hahnfeld, T D, Moon
openaire +2 more sources
Prostate cancer is the second leading cause of cancer death in men. Recommendations for screening and treatment are usually made, especially in the popular press, without regard to patient age or medical health. This article focuses on the trade-off between the benefits and side effects of screening and treatment.
L E, Hahnfeld, T D, Moon
openaire +2 more sources
Current Opinion in Oncology, 1997
Prostate cancer accounted for over 41,000 deaths in the United States in 1996. Prostate-specific antigen (PSA) screening is capable of detecting prostate cancer and appears to detect cancers that are both clinically significant as well as organ-confined, and therefore potentially curable. The positive predictive value of PSA value has been increased by
openaire +4 more sources
Prostate cancer accounted for over 41,000 deaths in the United States in 1996. Prostate-specific antigen (PSA) screening is capable of detecting prostate cancer and appears to detect cancers that are both clinically significant as well as organ-confined, and therefore potentially curable. The positive predictive value of PSA value has been increased by
openaire +4 more sources
The Lancet, 2008
In developed countries, prostate cancer is the second most frequently diagnosed cancer, and the third most common cause of death from cancer in men. Apart from age and ethnic origin, a positive family history is probably the strongest known risk factor.
Jan-Erik, Damber, Gunnar, Aus
openaire +2 more sources
In developed countries, prostate cancer is the second most frequently diagnosed cancer, and the third most common cause of death from cancer in men. Apart from age and ethnic origin, a positive family history is probably the strongest known risk factor.
Jan-Erik, Damber, Gunnar, Aus
openaire +2 more sources
JAAPA
Prostate cancer poses a substantial clinical challenge and accounts for a large proportion of cancer-related deaths worldwide. The therapeutic landscape has undergone a large transformation in the past 5 years, resulting in improved patient outcomes.
Valérie, Fonteyne +4 more
openaire +4 more sources
Prostate cancer poses a substantial clinical challenge and accounts for a large proportion of cancer-related deaths worldwide. The therapeutic landscape has undergone a large transformation in the past 5 years, resulting in improved patient outcomes.
Valérie, Fonteyne +4 more
openaire +4 more sources
Seminars in Oncology Nursing, 1993
Prostate cancer is the most common cancer in men and the second leading cause of cancer deaths. New advances in screening and imaging allow earlier diagnosis, and improved surgical techniques have reduced sexual dysfunction and incontinence that often resulted from radical prostatectomy. However, many questions remain.
openaire +2 more sources
Prostate cancer is the most common cancer in men and the second leading cause of cancer deaths. New advances in screening and imaging allow earlier diagnosis, and improved surgical techniques have reduced sexual dysfunction and incontinence that often resulted from radical prostatectomy. However, many questions remain.
openaire +2 more sources
Critical Reviews in Oncology/Hematology, 2005
Prostate carcinoma, with about 190,000 new cases occurring each year (15% of all cancers in men), is the most frequent cancer among men in northern and western Europe. Causes of the disease are essentially unknown, although hormonal factors are involved, and diet may exert an indirect influence; some genes, potentially involved in hereditary prostate ...
S. Bracarda +7 more
openaire +3 more sources
Prostate carcinoma, with about 190,000 new cases occurring each year (15% of all cancers in men), is the most frequent cancer among men in northern and western Europe. Causes of the disease are essentially unknown, although hormonal factors are involved, and diet may exert an indirect influence; some genes, potentially involved in hereditary prostate ...
S. Bracarda +7 more
openaire +3 more sources
JAMA: The Journal of the American Medical Association, 1992
To the Editor. —The study by Johansson et al 1 is of limited relevance because their selection criteria resulted in a study group that is not representative of the patient population with early prostate cancer. Their study group included an inordinately high proportion of men over the age of 75 years, most of whom had low-grade tumors too small to be ...
openaire +2 more sources
To the Editor. —The study by Johansson et al 1 is of limited relevance because their selection criteria resulted in a study group that is not representative of the patient population with early prostate cancer. Their study group included an inordinately high proportion of men over the age of 75 years, most of whom had low-grade tumors too small to be ...
openaire +2 more sources
Oncology Times, 2005
Prostate cancer is biologically and clinically a heterogeneous disease and its imaging evaluation will need to be tailored to the specific phases of the disease in a patient-specific, risk-adapted manner. We first present a brief overview of the natural history of prostate cancer before discussing the role of various imaging tools, including ...
openaire +3 more sources
Prostate cancer is biologically and clinically a heterogeneous disease and its imaging evaluation will need to be tailored to the specific phases of the disease in a patient-specific, risk-adapted manner. We first present a brief overview of the natural history of prostate cancer before discussing the role of various imaging tools, including ...
openaire +3 more sources